hepatic impairment
In patients with hepatic impairment the plasma concentrations of       troglitazone, M1 and M3 increase by 30%, 4-fold, and 2-fold, respectively.
In  @OBJECT$   @PREDICAT$   @SUBJECT$  the plasma concentrations of       troglitazone, M1 and M3 increase by 30%, 4-fold, and 2-fold, respectively.